NCT04652037View on ClinicalTrials.gov

Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 5, 2022

Conditions
CataractPresbyopiaCorneal Astigmatism
Interventions
DEVICE

Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Implantation

Implantation during bilateral cataract surgery of a new non-diffractive extended vision presbyopia and astigmatism correcting intraocular lens (Acrysof IQ Vivity Toric Extended Vision Intraocular Lens)

Trial Locations (1)

H2X 3E4

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT04652037 - Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens | Biotech Hunter | Biotech Hunter